ACUTE &LONG TERM HEMODYNAMIC EFFECTS &SAFTETY OF ACE II ISRBESARTAN IN HF

  • Mancini, Donna M. (PI)

Project: Research project

Project Details

Description

This study will evaluate acute & chronic hemodynamic effects of an angiotensin II receptor antagonist (ACEII), Irbesartan, in the treatment of heart failure (HF). ACE Inhibitors are standard medications used in treatment of HF. Those patients who remain symptomatic on their usual HF medications are ACE intolerant are eligible to participate in this study. Phase II.
StatusFinished
Effective start/end date10/1/959/30/98

Funding

  • National Center for Research Resources

ASJC Scopus Subject Areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.